Rosen, a leading law firm, encourages bioxcel therapeutics, inc. investors with losses to secure counsel before important deadline in securities class action - btai

New york , july 12, 2023 /prnewswire/ -- why: rosen law firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of bioxcel therapeutics, inc. (nasdaq: btai) between december 15, 2021 and june 28, 2023, both dates inclusive (the "class period"). a class action lawsuit has already been filed.
BTAI Ratings Summary
BTAI Quant Ranking